Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Penile Neoplasms × Vaccines, Synthetic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Condylomata Acuminata 9 Uterine Cervical Neoplasms 7 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Papillomavirus Infections 2 Uterine Cervical Dysplasia 1 Penile Neoplasms 1 Anus Neoplasms 1

Interventions

Vaccines, Synthetic 1 Paclitaxel 1 Ifosfamide 1 Fentanyl 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06465914 2024-12-12

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Shanghai Bovax Biotechnology Co., Ltd.

Phase 3 Active not recruiting

GastrointestinalGenitourinary

Anus Neoplasms, Condylomata Acuminata, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡